Visual Outcomes Associated With Patterns of Macular Edema Resolution in Central Retinal Vein Occlusion Treated With Anti–Vascular Endothelial Growth Factor Therapy

Author(s):  
Sarega Gurudas ◽  
Namritha Patrao ◽  
Luke Nicholson ◽  
Piyali Sen ◽  
Jayashree Ramu ◽  
...  
2016 ◽  
Vol 235 (2) ◽  
pp. 106-113 ◽  
Author(s):  
Teruyo Kida ◽  
Akitaka Tsujikawa ◽  
Yuki Muraoka ◽  
Seiyo Harino ◽  
Rie Osaka ◽  
...  

Purpose: To report a case series, whereby we encountered a transient increase in retinal cotton wool spots (CWS) following anti-vascular endothelial growth factor (anti-VEGF) therapy for the treatment of macular edema secondary to central retinal vein occlusion (CRVO). Methods: Eighteen eyes were treated with intravitreal aflibercept (IVA), and 5 were treated with intravitreal ranibizumab (IVR). Fundus photographs obtained 1 month after initial IVA or IVR injections were retrospectively evaluated for the presence of CWS. Results: Twenty-one (91.3%) patients had the following systemic diseases: hypertension, diabetes mellitus without retinopathy, dyslipidemia, or chronic renal failure requiring dialysis. One month after treatment, reduced macular edema was observed in 21 (91.3%) eyes. Initial injections facilitated complete resolution in 14 eyes, and CWS gradually became fainter with additional injections. Conclusion: Some eyes with CRVO-related macular edema can show a transient increase in CWS after initial anti-VEGF therapy; however, macular edema, retinal hemorrhage, and visual acuity were improved in almost every case.


Sign in / Sign up

Export Citation Format

Share Document